Job Trends
Thursday afternoon, Bellicum announced it will pause the development of its BCMA GoCAR-NK program and will also discontinue discovery research and new product development.
Labor Market Reports
BioSpace’s Q3 2025 U.S. Life Sciences Job Market Report reveals a turbulent quarter for biopharma hiring, with record declines in job postings, rising layoffs, and cautious employer sentiment shaping the industry’s employment landscape.
BioSpace data show biopharma professionals faced increased competition for fewer employment opportunities during the second quarter of 2025, with increased pressure from further layoffs.
Establishing trust through thought leadership is no longer optional in today’s cautious biopharma market. Learn how strategic insights and targeted outreach can turn awareness into high-converting leads.
Now Hiring
Looking for a biopharma job in New York? Check out the BioSpace list of eight companies hiring life sciences professionals like you.
Of the 25 companies receiving tax incentives in Massachusetts, 23 will add jobs outside of Boston and Cambridge. Medtronic, which is receiving the largest award, will create 220 roles in Billerica. Other recipients include AbbVie, Dyne Therapeutics and Viridian Therapeutics.
Looking for a job in regulatory? Check out the BioSpace list of eight companies hiring life sciences professionals like you.
THE LATEST
Less than one month after announcing plans for construction of a South Carolina manufacturing facility, Arthrex announces its plans for the expansion of its global headquarters in Florida.
Abeona Therapeutics has plans to expand its facilities and hire an additional 25 to 40 employees.
Sangamo is moving its corporate headquarters to a new site at Oyster Point in Brisbane, CA.
The cash will allow the company to hire scientists to conduct preclinical research into a potential treatment for DMD.
A little more than one year after securing $130M in financing, molecular technology company Zymergen has expanded beyond the Golden State to the Emerald City, Seattle.
The company plans to invest nearly $10 million over five years to establish operations in Indiana.
CryoPort handles the products for more than 172 of the more than 800 immunotherapy trials underway.
Want to work for a company having a growth spurt?
New positions have been announced at Regeneron as the company’s Irish bioprocessing campus receives an additional $100m in funding.
A venture of Anhui Chem Bright Bioengineering Co. Ltd. named KB Biotech Solutions, is opening a manufacturing facility in Dillon County, SC.